Exhaled nitric oxide during incremental and constant workload exercise in chronic cardiac failure

Background Nitric oxide (NO) is present in exhaled breath and produced by the pulmonary vascular endothelium as a potent vasodilator. Exercise is normally associated with pulmonary vasodilatation and a decrease in pulmonary vascular resistance to accommodate the increase in cardiac output. If production of NO is impaired in patients with chronic congestive cardiac failure (CCF), this might contribute to their exercise intolerance. Patients and methods We quantified NO production (V˙ NO) in 12 patients with chronic stable CCF and 12 controls, at rest and during incremental cardiopulmonary exercise on a treadmill, and at a later date during constant workload exercise. Results Patients had reduced V˙ NO compared with controls during incremental exercise [381 (180) vs. 777 (275) nL min−1; mean (SD); P < 0.0001] but at constant workload V˙ NO was similar between the two groups [353 (124) vs. 389 (189) nL min−1; P = 0.25]. Plasma levels of nitrate, the stable end-product of NO production, were significantly higher in patients [resting value 46.1 (21.6) vs. 23.0 (10.0) μM; P = 0.004] and were not influenced by exercise. Conclusion Impaired NO-mediated pulmonary vasodilatation does not appear to contribute to exercise limitation in CCF. Alternatively, the lower NO production observed during maximal exercise in the patient group compared with controls may reflect a reduced incremental response of a system that is already abnormally activated in heart failure.